Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News on Diabetes

Novo Nordisk Poised For UNH-Style Comeback: New Data & AI Boost Signal Reversal

Novo Nordisk A/S (NYSE:NVO) looks ready to shake off its slump. With weight-loss pills showing blockbuster results, Ozempic proving heart-healthy benefits, and analysts flipping bullish, the stock is starting to resemble UnitedHealth Group Inc.'s (NYSE:UNH) rebound playbook.

Benzinga

Short Report Alleges Dexcom Sold Faulty G7 Device Cited By FDA

Hunterbrook Media released a short report on diabetes-focused DexCom Inc. (NASDAQ:DXCM), citing that the company sold the "adulterated" device.

Benzinga

‘Pioneering’ new weight-loss jab could help keep weight off even after you stop taking it

The downfall of drugs such as Mounjaro, Ozempic and Wegovy is many patients regain weight shortly after stopping

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Could This Eli Lilly Oral Pill Be Key To Significant Weight Loss?

Eli Lilly and Co (NYSE:LLY) on Tuesday shared detailed results from the Phase 3 ATTAIN-1 trial, evaluating the safety and efficacy of oral orforglipron in adults with obesity, or overweight with a weight-related medical problem, and without diabetes.

Benzinga

Vital breakthrough as once-a-day pill can help people lose ‘significant’ weight

A fifth of people taking the weight-loss tablet Orforglipron lost 20 per cent of their body weight

The Independent UK

Study recommends ‘planetary diet’ to cut diabetes risk and emissions

Researchers say dietary changes are crucial part of effort to tackle global heating

The Independent UK

Weight-loss drugs help stop intrusive thoughts about food, study finds

Wegovy also was found to improve mental health, self-confidence and the development of healthier habits

The Independent UK

Read news from The Economist, FT, and more,
with one subscription

Wegovy's Next Step: Novo Nordisk Eyes Approval for Higher-Dose Treatment

Novo Nordisk A/S (NYSE:NVO) reportedly said on Tuesday that it intends to seek US regulatory approval for a high-dose version of its weight-loss injection Wegovy (semaglutide), another effort to counter Eli Lilly and Co. (NYSE:LLY).

Benzinga

Weight loss jabs could be effective on children as young as six, study suggests

The report did warn that stomach problems are more common among youngsters taking the drugs.

Evening Standard

Obese children as young as six could benefit from weight-loss jabs

About a third of children leaving primary school are overweight or living with obesity in England

The Independent UK

More of the world's children are obese than underweight, UN warns

For the first time, more school-aged children are obese than underweight around the world, with the exception of sub-Saharan Africa and South Asia. The warning came in a report released on Wednesday by the United Nations children’s agency Unicef.

Radio France Internationale

Why have energy drinks been banned for under-16s in England? The real question is why it wasn’t done sooner

Expecting parents to police kids’ intake of a psychoactive drug is unrealistic and unfair given the power of social media, says Prof Devi Sridhar, chair of global public health at the University of Edinburgh

The Guardian - UK

More children now obese than underweight for first time ever

Major study by Unicef finds 391 million children across the globe now overweight or obese

The Independent UK

Novo Nordisk, maker of obesity drug Wegovy, to cut 9,000 jobs to sharpen focus, meet competition

Danish pharmaceutical company Novo Nordisk, maker of weight-loss drug Wegovy, said Wednesday it would cut 9,000 jobs, 5,000 of them in Denmark, in order to strengthen the company’s focus on growth opportunities in obesity and diabetes medications

The Independent UK

Get all your
news in one place.

100's of premium titles.
One news app.

The Guardian - UK

Junk food leads to more children being obese than underweight for first time

Cheap ultra-processed food behind rise in overweight children, with one in 10 now obese globally, says Unicef

The Independent UK

Almost half of those with diabetes don’t know they have it. Are you one of them?

Diabetes affects 38.4 million Americans, according to the Centers for Disease Control and Prevention

The Independent UK

UK ‘falling behind’ when it comes to diabetes diagnosis, study says

Among western European countries, only Switzerland and France had lower diagnosis rates than the UK

The Independent UK

Weight-loss jabs are not enough to tackle the obesity crisis, experts warn

THE UK’S OBESITY CHALLENGE : Weight-loss drug Mounjaro will be rolled out to a quarter of a million NHS patients. But leading experts tell Rebecca Thomas and Alicja Hagopian that weight-loss jabs alone will not be enough to solve the obesity crisis

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

WHO has added GLP-1 drugs to the essential medicines list. Here’s what that means

GLP-1 drugs were initially developed for diabetes, but have become wildly popular weight-loss drugs too

International Business Times

WHO Backs Weight-loss Drugs, Urges Cheap Generics

The World Health Organization recommended a range of blockbuster weight-loss drugs to treat diabetes and obesity globally for the first time on Friday, calling for cheap generic versions to be made available for people in developing countries.

The Independent UK

Error means 55,000 patients require diabetes retests after potential misdiagnoses

More than 55,000 patients may require new blood tests to receive an accurate blood glucose reading

AAP

Softies take a hit as nation sours on sweetened drinks

Health organisations say data revealing fewer Aussies are drinking sweetened drinks is encouraging, but more work is needed to incentivise healthy choices.

The Independent UK

New technology for diabetic pregnant women will reduce risk of miscarriage and stillbirth

The new technology, known as a hybrid closed loop system, will help reduce the risk of stillbirth and miscarriage

The Independent UK

Mapped: NHS patients facing postcode lottery for weight-loss jab Mounjaro

It’s estimated that 3.4 million people in the UK could benefit from taking a weight-loss jab like Mounjaro

The Independent UK

Scientists say there is no link between ‘microdosing’ weight-loss drugs and living longer

It is ‘too early’ to know whether small doses of weight-loss drugs can help you live longer, experts say

1 … 12 13 14 15

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the World Health Organization

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.